Rapid memory T-cell reconstitution recapitulating CD45RA-depleted haploidentical transplant graft content in patients with hematologic malignancies.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

14 citing papers in PubMed.

1. Selective T-cell depletion targeting CD45RA reduces viremia and enhances early T-cell recovery compared with CD3-targeted T-cell depletion.Transplant infectious disease : an official journal of the Transplantation Society · 2018
   Trial
2. Consolidation Therapy for Newly Diagnosed Pediatric Patients with High-Risk Neuroblastoma Using Busulfan/Melphalan, Autologous Hematopoietic Cell Transplantation, Anti-GD2 Antibody, Granulocyte-Macrophage Colony-Stimulating Factor, Interleukin-2, and Haploidentical Natural Killer Cells.Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation · 2017
   Trial
3. Donor lymphocyte infusion as immune modulation after pediatric allogeneic transplantation.Blood immunology & cellular therapy · 2026
   Article
4. Selective depletion of naïve T cells by targeting CD45RA.Frontiers in oncology · 2022
   Review
5. Controversies and expectations for the prevention of GVHD: A biological and clinical perspective.Frontiers in immunology · 2022
   Review
6. Comparison of clinical outcomes between unrelated single umbilical cord blood and "ex-vivo" T-cell depleted haploidentical transplantation in children with hematological malignancies.World journal of pediatrics : WJP · 2021
   Article
7. Improved hematopoietic stem cell transplantation upon inhibition of natural killer cell-derived interferon-gamma.Stem cell reports · 2021
   Article
8. Contemporary haploidentical stem cell transplant strategies in children with hematological malignancies.Bone marrow transplantation · 2021
   Review
9. Allogeneic CAR Cell Therapy-More Than a Pipe Dream.Frontiers in immunology · 2020
   Review
10. Key Aspects of the Immunobiology of Haploidentical Hematopoietic Cell Transplantation.Frontiers in immunology · 2020
    Review
11. Adoptive T Cell Therapy Following Haploidentical Hematopoietic Stem Cell Transplantation.Frontiers in immunology · 2019
    Review
12. Epigenetic Maintenance of Acquired Gene Expression Programs during Memory CD8 T Cell Homeostasis.Frontiers in immunology · 2018
    Review
13. Human memory CD8 T cell effector potential is epigenetically preserved during in vivo homeostasis.The Journal of experimental medicine · 2017
    Article
14. Novel treatment of severe combined immunodeficiency utilizing ex-vivo T-cell depleted haploidentical hematopoietic stem cell transplantation and CD45RA+ depleted donor lymphocyte infusions.Orphanet journal of rare diseases · 2016
    Article

Corrections and comments

• Erratum for
  Rapid memory T-cell reconstitution recapitulating CD45RA-depleted haploidentical transplant graft content in patients with hematologic malignancies.2015

Authors and funding

14 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.